EnteroMedics Reports Publication of 3-Year Data from vBloc Diabetic Patient Study in Journal of Diabetes, Obesity: 'Demonstrates Significant and Sustained Weight Loss and Glycemic Control in Obese Patients with Type 2 Diabetes'